On the contrary, the non-CSC population (i.e., CD34− cells), which constitutes the bulk of the tumor, confirmed a high D2 and NANOG expression level at the early stages of tumorigenesis, one and two weeks following tumor induction (Figure 3G). This evidence concerns the gene CD34 and neoplasm.